In‐Ho Kim

1.1k total citations
23 papers, 261 citations indexed

About

In‐Ho Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, In‐Ho Kim has authored 23 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in In‐Ho Kim's work include Gastric Cancer Management and Outcomes (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). In‐Ho Kim is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). In‐Ho Kim collaborates with scholars based in South Korea, United States and Hungary. In‐Ho Kim's co-authors include Myung Ah Lee, Se Jun Park, Sung Hak Lee, Han Hong Lee, Kyo Young Song, Jae Myung Park, Dong Hoon Kang, Hyunho Kim, Ji Hyun Yang and Cho Hyun Park and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Molecules.

In The Last Decade

In‐Ho Kim

23 papers receiving 260 citations

Peers

Countries citing papers authored by In‐Ho Kim

Since Specialization

Citations

This map shows the geographic impact of In‐Ho Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In‐Ho Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In‐Ho Kim more than expected).

Fields of papers citing papers by In‐Ho Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In‐Ho Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In‐Ho Kim. The network helps show where In‐Ho Kim may publish in the future.

Co-authorship network of co-authors of In‐Ho Kim

This figure shows the co-authorship network connecting the top 25 collaborators of In‐Ho Kim. A scholar is included among the top collaborators of In‐Ho Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In‐Ho Kim. In‐Ho Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings 2025 ·Scientific Reports ·Se Jun Park, (unknown), In‐Ho Kim, Myung Ah Lee, Tae Ho Hong, Hyunho Kim	1
2	Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024 2025 ·Journal of the Korean Gastric Cancer Association ·(unknown), Ichiro Uyama, Sun Young Rha, Maria Bencivenga, Ji Yeong An, Lucjan Wyrwicz, Dong‐Hoe Koo, Richard van Hillegersberg, Keun‐Wook Lee, Guoxin Li, Takaki Yoshikawa, Brian D. Badgwell, Sylvie Lorenzen, In‐Ho Kim, In‐Seob Lee, Hye Sook Han, Hoon Hur	2
3	Description of FDG and Prostate-Specific Membrane Antigen PET/CT Findings in Korean Patients With Advanced Metastatic Castration-Resistant Prostate Cancer 2024 ·Korean Journal of Radiology ·Sae Jung Na, Seunggyun Ha, In‐Ho Kim, Ji Youl Lee, Joo Hyun O	3
4	Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater 2024 ·BMC Cancer ·(unknown), Se Jun Park, (unknown), Tae Ho Hong, In‐Ho Kim, Myung Ah Lee	1
5	Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial 2024 ·Gastric Cancer ·Zev A. Wainberg, Yoon‐Koo Kang, Keun‐Wook Lee, Shukui Qin, Kensei Yamaguchi, In‐Ho Kim, Anwaar Saeed, Sang Cheul Oh, Jin Li, Hacı Mehmet Türk, Alexandra Teixeira, Erika Hitre, (unknown), Giovanni Gerardo Cardellino, (unknown), Anita Zahlten‐Kumeli, Kate Taylor, Peter C. Enzinger	30
6	Prognostic Significance of EGFR, HER2, and c-Met Overexpression in Surgically Treated Patients with Adenocarcinoma of the Ampulla of Vater 2024 ·Cancers ·Se Jun Park, (unknown), Tae Ho Hong, Sung Hak Lee, In‐Ho Kim, Young-Hoon Kim, Myung Ah Lee	2
7	A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation 2023 ·Journal of the Korean Gastric Cancer Association ·(unknown), Hyunho Kim, (unknown), Hyung Soon Park, Ho Jung An, In Sook Woo, Jae Ho Byun, Ji Hyung Hong, Yoon Ho Ko, Der Sheng Sun, Hye Sung Won, Jong‐Youl Jin, (unknown), In‐Ho Kim, (unknown), Byoung Yong Shim	2
8	Early Increase in Circulating PD-1+CD8+ T Cells Predicts Favorable Survival in Patients with Advanced Gastric Cancer Receiving Chemotherapy 2023 ·Cancers ·(unknown), (unknown), Se Jun Park, Hyunho Kim, Myung Ah Lee, (unknown), Juyeon Park, Nahyeon Kang, In‐Ho Kim	4
9	Emerging Targets for Systemic Treatment of Gastric Cancer: HER2 and Beyond 2023 ·Journal of the Korean Gastric Cancer Association ·In‐Ho Kim	11
10	Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer 2023 ·BMC Cancer ·Se Jun Park, (unknown), (unknown), Tae Ho Hong, Myung Ah Lee, Young-Hoon Kim, In‐Ho Kim	17
11	Histologic subtype-based evaluation of recurrence and survival outcomes in patients with adenocarcinoma of the ampulla of Vater 2023 ·Scientific Reports ·Se Jun Park, (unknown), Tae Ho Hong, Sung Hak Lee, In‐Ho Kim, Young-Hoon Kim, Myung Ah Lee	1
12	Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy 2023 ·Scientific Reports ·(unknown), (unknown), Se Jun Park, Myung Ah Lee, Jae Myung Park, Myung‐Gyu Choi, (unknown), Kyo Young Song, Han Hong Lee, Ho Seok Seo, Sung Hak Lee, Bohyun Kim, (unknown), (unknown), Nahyeon Kang, In‐Ho Kim	24
13	ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer 2022 ·Clinical Cancer Research ·(unknown), John D. Karalis, Changjin Hong, Jean R. Clemenceau, Matthew R. Porembka, In‐Ho Kim, Sung Hak Lee, Sam C. Wang, Jae‐Ho Cheong, Tae Hyun Hwang	21
14	Determination of the extent of dissection in early gastric cancer based on lymph node station power index 2022 ·BJS Open ·(unknown), (unknown), Sojung Kim, Ho Seok Seo, In‐Ho Kim, Kyo Young Song, Han Hong Lee	4
15	Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy 2021 ·World Journal of Gastrointestinal Oncology ·(unknown), (unknown), Se Jun Park, (unknown), In‐Ho Kim, Myung Ah Lee	14
16	Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer 2021 ·The Korean Journal of Internal Medicine ·Se Jun Park, Jin Soo Lee, Hyunho Kim, (unknown), Myung Ah Lee, Jae Myung Park, Myung‐Gyu Choi, Cho Hyun Park, Kyo Young Song, Han Hong Lee, In‐Ho Kim	20
17	Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer 2020 ·Journal of the Korean Gastric Cancer Association ·(unknown), (unknown), Jae Myung Park, Han Hong Lee, Kyo Young Song, Sung Hak Lee, Bohyun Kim, Sang‐Yeob Kim, (unknown), (unknown), Sang-Young Roh, In‐Ho Kim	21
18	Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage 2019 ·BMC Cancer ·(unknown), Se Jun Park, Jin Soo Lee, Cho Hyun Park, Kyo Young Song, Han Hong Lee, Ho Seok Seo, Yoon Ju Jung, Jae Myung Park, Sung Hak Lee, (unknown), In‐Ho Kim	17
19	Standardized Citrus unshiu peel extract ameliorates dexamethasone-induced neurotoxicity and depressive-like behaviors in mice 2018 ·Metabolic Brain Disease ·Dong Wook Lim, Min Young Um, (unknown), Jaekwang Lee, Yun Tai Kim, Suengmok Cho, In‐Ho Kim, Daeseok Han, Chang-Ho Lee	15
20	Discordancy and changes in the pattern of programmed death ligand 1 expression before and after platinum-based chemotherapy in metastatic gastric cancer 2018 ·Gastric Cancer ·Ji Hyun Yang, Hyunho Kim, (unknown), Myung Ah Lee, Jae Myung Park, Han Hee Lee, Cho Hyun Park, Han Hong Lee, Eun Sun Jung, Sung Hak Lee, Young Joon Lee, Moon Hyung Choi, (unknown), In‐Ho Kim	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact